News

Roche’s hopes of getting its chronic obstructive pulmonary disease (COPD) drug astegolimab to regulators this year have taken ...
For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol, according ...
Patients with COPD and chronic hypercapnic respiratory failure on noninvasive ventilation report similar quality of life ...
The path to market for Roche’s astegolimab became more uncertain after the investigational antibody failed to significantly ...
DEAR PEOPLE’S PHARMACY: My father has severe COPD. The doctors at the Department of Veterans Affairs hospital prescribed ...
Chronic obstructive pulmonary disease (COPD) is a major global health problem that is becoming prevalent, particularly in developing countries 1.It is one of the most common diseases in the world ...
Chronic obstructive pulmonary disease causes 2.5 times more deaths in men than in women. From 2001 to 2019, mortality due to that pathology declined by 43% in men and women.
Inhaler Misuse in Chronic Obstructive Pulmonary Disease. by Swethapriya Sampath on Aug 22 2024 12:40 PM. Listen to this article. 0:00 / 0:00.
How gum disease aggravates chronic obstructive pulmonary disease. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2024 / 01 / 240114212121.htm ...
Chronic obstructive pulmonary disease (COPD) is a genetically and environmentally determined disease characterized by airflow limitation that is not fully reversible (reviewed by Barnes). 1 The ...